Cárdenas-Velázquez F, Hernández-Molina G

Language: Spanish
References: 18
Page: 231-234
PDF size: 46.79 Kb.

ABSTRACT

Objective: To review the cases of optic neuritis in the population of patients with Systemic Lupus Erythematosus (SLE) who attends to the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Material and methods. We included 12 patients with optic neuritis who fulfilled the ACR SLE criteria. Age, gender, previous treatment, unilateral or bilateral involvement, recurrence, other concomitant neurologic symptoms, SLE activity, anticardiolipin antibodies and visual outcome were recorded. Results. The female:male ratio was 5:1. The mean age of the study group was 33 ± 13 years. In two patients the optic neuritis antedated the SLE diagnosis, in one the event presented at the same time of lupus onset, and in the rest of the patients the optic neuritis postdated the diagnosis of SLE. The median SLE duration was three years (1-12). At the optic neuritis onset, four of the patients also presented other lupus manifestations whereas the rest of them were in remission. The event was bilateral in 33% and recurrent in three patients (median two events 2-6). In three cases an event of transverse myelitis was also documented. Only one of the patients had an established diagnosis of antiphospholipid syndrome, however eight were positive for anticardiolipin antibodies. Besides treatment with steroids and in two cases with cyclophosphamide, five of the patients had blindness and only four regained normal visual acuity. Conclusion. Although optic neuritis is a rare manifestation in SLE patients, it is a cause of blindness.

REFERENCES

1. Balcer L. Optic neuritis. N Engl J Med 2006; 354: 1273-80.

2. Fragoso-Loyo H, Sánchez-Guerrero J. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus. J Rheumatol 2007; 34: 76-80.

3. Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology 2007; 46: 1757-62.

4. Lateef A, Lim AY. Case reports of transient loss of vision and systemic lupus erythematosus. Ann Acad Med Singapore 2007; 36: 146-9.

5. Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum 1988; 31: 1105-10.

6. Smith C, Pinals R. Optic neuritis in Systemic Lupus Erythematosus. J Rheumatol 1982; 9: 963-6.

7. Jabs DA, Miller NR, Newman SA, Johnson MA, Stevens MB. Optic neuropathy in systemic lupus erythematosus. Arch Ophtalmol 1986; 104: 564-8.

8. Giorgi D, Balacco C. Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): Clinical features, pathogenesis, review of the literature and proposed ophtalmological criteria for APS diagnosis. Clin Rheumatol 1999; 18: 124-31.

9. Lin YC, Wang AG, Yen MY. Systemic lupus erythematosusassociated optic neuritis: clinical experience and literature review. Acta Ophtalmol 2009; 87: 204-10.

10. Fernández FJ, Fernández JR, Pérez S, Rodríguez M, Mardomingo P. Neuritis óptica como primera manifestación de LES. An Med Interna 2004; 21(7): 366.

11. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology 1997; 49: 1404-13.

12. Barkeh H, Muhaya M. Optic neuritis and retinal vasculitis as primary manifestations of SLE. Med J Malaysia 2002; 57: 490-2.

13. Mok C, Lau C, Chan E, Wong R. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment and outcome. J Rheumatol 1998; 25: 467-73.

14. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Rujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.

15. Pittock S, Lennon V, De Seze J, Vermershc P, Homburger H, et al. Nueromyelitis optic and nonorgan–specific autoimmunity. Arch Neurol 2008; 65(1): 78-83.

16. Galindo-Rodriguez G, Avina-Zubieta A, Pizarro S, Diaz de Leon V, Saucedo N, Fuentes M, Lavalle C. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: a open trial. Am J Med 1999: 106(1): 65-9.

17. Rosenbaum J, Simpson J, Neuwelt C. Successful treatment of optic neuropathy in association with SLE using iv cyclophosphamide. Br J Ophtalmol 1997; 81: 130-2.

18. Beck R, Cleary P, Anderson M, Keltner J, Sults W, Kaufman D, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992; 326: 581-8.